HEALTH BLOGS
HEALTH BLOGS
category: health
08 Sep 2008
Here is an interview with the single largest user of collagen in the world. A day in the life of the King of Collagen, you might say. If you’ve thought about dermatological injections, you should definitely check it out…

Dr Frederic Brandt has several claims to fame. He is, for instance, the largest user of injectable collagen and Botox - in the world. ‘I just love fillers!’ he tells me. And how. When we meet at his New York clinic he wastes no time in revealing that he regularly injects himself.

‘The last session I did was six-and-a-half vials!’ His face is a smooth, jowl-free mask. Imagine a tub of frozen yoghurt, not a single line or wrinkle. He is cosmetic medicine’s Peter Pan.

In fact, in the 25 years since he began practising (Brandt set up shop in 1982 after completing both an oncology and dermatology residency at medical school in Philadelphia) he has personally tested every procedure and product he uses in his clinics - on himself.

All of which has made the 59-year-old Brandt surreally young-looking, and very rich. He is the Baron of Botox, the King of Collagen. His clients pay up to $7,000 for a full face of injections and come to him from all over the world, some as often as six times a year.

Read more…

POST YOUR COMMENTS
category: health
07 May 2008

Beverly Hills, CA (PRWEB) May 7, 2008 — Dr. Simon Ourian of Epione in Beverly Hills criticizes the claims made by the Italian National Research Council’s study that BOTOX® can move to the brain from the injection site. “BOTOX® has been used safely for more than 25 years with few complications. This fear is completely unwarranted and largely alarmist,” explains Dr. Ourian.

The Journal of Neuroscience article (A New Reason to Frown; April 12), draws inappropriate conclusions about the medical product BOTOX® (Botulinum Toxin Type A), how it works in treating millions of patients suffering from severe conditions and incorrectly calls into question its 19-year safety record. “Although the study makes for great eyebrow raising news the science behind the study is largely flawed,” says Dr. Ourian.

BOTOX® is the safest anti-aging treatment out there, I use it myself and recommend it to all my patients.
  • The article centers on a single Italian rat study that has no proven relevance to the use of BOTOX® in humans.
  • Importantly, the study authors did not use BOTOX® in their research. Instead, they used a research-grade, laboratory preparation of botulinum toxin that is not suitable for human use. This study material is substantially different than BOTOX® and reacts differently in the body.
  • Furthermore, the dosing of study material injected in the whisker pad of rats was approximately 150 times higher (per body weight) than the approved dose for BOTOX® to treat wrinkles (i.e., glabellar lines).
  • Researchers did not directly detect the laboratory material in the rats; instead, they inferred its presence through the use of a marker. However, this marker has not been previously used in peer-reviewed research in this manner and is not validated. The use of this uncharacterized marker brings the study and its conclusions into question, since the study’s results entirely depend upon it.
  • BOTOX® was first approved by the FDA for medical use nearly 20 years ago, has been extensively studied, and is the subject of thousands of scientific papers.
  • The data from this single rat study are inconsistent with prior research and the literature on the mechanism of action of BOTOX®. There are insufficient data to generalize the results of this one animal study to the use of BOTOX®.
  • BOTOX® has brought relief to millions of patients worldwide suffering from often severely debilitating medical conditions. It is inappropriate to create unnecessary concern and confusion among those who need this treatment by mischaracterizing the established safety of this drug.

“There is no chance that the results of this study could occur in a human. The doses used for cosmetic application are much smaller and the effects more localized. I always support additional research, but this study contradicts previous findings,” says Ourian. “BOTOX® is the safest anti-aging treatment out there, I use it myself and recommend it to all my patients.” Dr. Ourian’s Epione Medical Center, located in Beverly Hills’ “Golden Triangle,” is among the world’s most comprehensive and state-of-the-art surgery centers. Dr. Ourian has been a pioneer for laser technology and non-invasive aesthetic procedures such as BOTOX®, Restylane®, Radiesse®, Lipotherapy, and CoolaserTM. For further information, please visit www.epione.com.

POST YOUR COMMENTS
category: health
23 Jul 2007

WALTHAM, Mass., July 23 /PRNewswire/ — Millennium Research Group has conducted a detailed analysis of the therapeutic botulinum toxin (BTX) market in its Global Markets for Therapeutic Botulinum Toxin 2007 report. The analysis reveals that an increasing number of patients will receive BTX treatment for therapeutic use over the next five years in the US as there is an expanding range of indications which will drive the market to over $850 million by 2012; a 15% growth rate over 2006.

Toward the end of 2012, new therapeutic BTX indications are expected to be approved and reimbursed which will drive unit sales in the US. In 2009, Allergan anticipates that Botox will be approved for the treatment of chronic daily headache, a condition that affected nearly 2 million people in the US in 2003.

“Allergan also expects to receive Botox approval for neurogenic and idiopathic overactive bladder (OAB) in 2010 and 2011, respectively,” says Leonard Machler, Analyst at MRG. “Although the effect of OAB treatment on BTX procedural volumes will largely occur beyond 2012, there has been considerable interest in treating these conditions with BTX.”

The Global Markets for Therapeutic Botulinum Toxin 2007 report provides coverage of the US, Europe, and Japan. Selected companies covered in this report include Allergan, Ipsen, Medy-Tox, Merz Pharmaceuticals, and Solstice Neurosciences.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (HTTP://www.DecisionResources.com, is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

POST YOUR COMMENTS